Literature DB >> 15815036

Evaluation of a rapid assay as an alternative to conventional enzyme immunoassays for detection of hepatitis C virus-specific antibodies.

Hubert Darius J Daniel1, Priya Abraham, Sukanya Raghuraman, Perumal Vivekanandan, Thenmozhi Subramaniam, Gopalan Sridharan.   

Abstract

A rapid membrane flow-through immunoassay to detect antibodies to hepatitis C virus was compared with a commercial enzyme immunoassay (EIA) and microparticle enzyme immunoassay (MEIA) using 2,590 serum samples. Sensitivity and specificity of the "rapid assay" in comparison to the EIA/MEIA were 99.3 and 99.0%; the correlation coefficient being 0.91. This assay is suitable where infrastructure and laboratory expertise are limited.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15815036      PMCID： PMC1081346          DOI： 10.1128/JCM.43.4.1977-1978.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996.

Authors:  A Nanu; S P Sharma; K Chatterjee; P Jyoti
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

2.  Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India.

Authors:  Sukanya Raghuraman; R V Shaji; Gopalan Sridharan; Sujatha Radhakrishnan; George Chandy; B S Ramakrishna; Priya Abraham
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

3.  Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India.

Authors:  S Radhakrishnan; P Abraham; S Raghuraman; G T John; P P Thomas; C K Jacob; G Sridharan
Journal:  Indian J Med Res       Date:  2000-06       Impact factor: 2.375

4.  Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.

Authors:  Z X Zhang; M Chen; A Sönnerborg; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
  4 in total
  7 in total

Review 1.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Diagnostic reliability of Architect anti-HCV assay: Experience of a tertiary care hospital in India.

Authors:  Gnanadurai John Fletcher; Anantharam Raghavendran; Jayashree Sivakumar; Prasanna Samuel; Priya Abraham
Journal:  J Clin Lab Anal       Date:  2017-06-28       Impact factor: 2.352

3.  Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysis.

Authors:  Mehnaaz Sultan Khuroo; Naira Sultan Khuroo; Mohammad Sultan Khuroo
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

4.  Reexamination of the relationship between the prevalence of hepatitis C virus and parenteral antischistosomal therapy among Egyptians resident in Qatar.

Authors:  Moutaz Derbala; Prem Chandra; Aliaa Amer; Anil John; Manik Sharma; Ashraf Amin; Ragesh Babu Thandassery; Amr Faris
Journal:  Clin Exp Gastroenterol       Date:  2014-11-03

Review 5.  Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature.

Authors:  Weiming Tang; Wen Chen; Ali Amini; Debi Boeras; Jane Falconer; Helen Kelly; Rosanna Peeling; Olivia Varsaneux; Joseph D Tucker; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

Review 6.  Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies.

Authors:  Shrikant Dashrath Warkad; Keum-Soo Song; Dilipkumar Pal; Satish Balasaheb Nimse
Journal:  Sensors (Basel)       Date:  2019-09-30       Impact factor: 3.576

7.  Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers.

Authors:  Rajiv Kumar Mondal; Mousumi Khatun; Priyanka Banerjee; Alip Ghosh; Sumanta Sarkar; Amal Santra; Kausik Das; Abhijit Chowdhury; Soma Banerjee; Simanti Datta
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.